3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
OTHER
211
NIH
29
INDUSTRY
21
NETWORK
13
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
3
Plasma cell
1
Other hematologic neoplasm
1
Conditions
Multiple Myeloma
1
Interventions
Dexamethasone
4
Cyclophosphamide
4
pomalidomide
2
pegylated granulocyte colony-stimulating factor
2
pegfilgrastim
2
fludarabine
2
carfilzomib
2
Etoposide
2
Cytarabine
2
Bortezomib
2
fosaprepitant
1
fludarabine phosphate
1
daratumumab
1
Zoledronic Acid
1
Vaccination
1
Tropisetron
1
Thiotepa
1
Renal Replacement Therapy
1
Prednisone
1
Pneumococcal Vaccines
1
Olanzapine
1
Melphalan
1
Lenalidomide
1
Granulocyte Colony-Stimulating Factor
1
Cyclosporine
1
Azacitidine
1
Atorvastatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Melphalan
×
Plasma cell
×
Clear all
NCT02773550
2020-01-18
Velcadito
Basque Health Service
Phase 4
Terminated
24 enrolled